Study of AT-752 in Patients With Dengue Infection
Study sponsor: Atea Pharmaceuticals, Inc. · AVIR
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-01-19Actual
Enrollment · participants21Actual
Source updated2024-03-05Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.